News & Current Events
- Johnson & Johnson: We're Creaming Medivation, Inc., Boehringer Ingelheim Corporation, Bristol-Myers Squibb Company and Pfizer Inc.
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Im at Johnson & Johnsons Pharmaceutical Business Review today. Most of the day is dedicated to geeky drug R&D stuff, but Joaquin Duato started of the morning with a run-down of how J&Js pharmaceutical division... - Merck Serono Courting Biotechnology Start-ups
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Stefan Oschmann came courting biotechnology start-ups last week, a trans-Atlantic visitor promising not only pharmaceutical industry expertise but also cash. Oschmann, who made his pitch to several dozen area... - AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) Drops as Astellas Pharma Inc. Will Not Seek Nod for Kidney Cancer Drug
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe. Aveo shares... - Drug Giants Such as Bayer AG, Pfizer Inc., and Roche Accused of Shady Soviet-Era Drug Trials
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Germanys Der Spiegel recently published a string of articles indicating that, until the fall of the Berlin Wall, major pharmaceutical companies conducted hundreds of drug trials in East Germany. In all, the... - Vaccine Blackjack: IL-21 Critical to Fight Against Viral Infections, Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections. The results are published in the... - How Scripted Aegerion Pharmaceuticals, Inc.'s Success Story
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
When Marc Beer sold his ?rst public company, the biotech ViaCell, to PerkinElmer for $300 million in 2007 it seemed like the beginning of an amazing entrepreneurial career. But just months later it was cut... - Universal Flu Jab "Edges Closer," Nature Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A way of creating more effective vaccines which could protect against a broad range of flu viruses has been reported by US researchers. A different seasonal flu jab is produced every year as the virus is a... - Pfizer Inc. Takes Its Shot at a Vaccine for Evasive MRSA Superbug
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia... - Drugs Found to Both Prevent and Treat Alzheimer's Disease, University of Southern California Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Imagine a pharmaceutical prevention, treatment or even cure for Alzheimer's disease. It is almost impossible to overstate how monumental a development that would be and how it would answer the prayers of millions... - The Logic of Biologics - Is Regeneron Pharmaceuticals, Inc. the Next Genentech?
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
When the US biotech company Regeneron Pharmaceuticals recently announced its first-quarter results, few were surprised that the companys flagship wet age-related macular degeneration (AMD) product Eylea... - AstraZeneca PLC Closes in on Site for New $500 Million Home in Cambridge
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry sources said. Moving research and... - Teva Pharmaceutical Industries Limited Bets on Reformulating Old Drugs as Investors Say "Show Me"
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts highest-rated stock among the worlds 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy... - Takeda Pharmaceutical Co. Ltd. Recalls Batch of Anemia Therapy Rienso in Switzerland After Patient Death
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity... - Keeping Stem Cells Strong: RNA Molecule Protects Stem Cells During Inflammation, California Institute of Technology Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness. But repeated infections and inflammation... - Swiss Billionaires Buy Merck Serono HQ for Biotech Campus
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker... - Johnson & Johnson to "Wrap Up" Pakistan Operations
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Johnson & Johnson Pakistan (Pvt) Limited has decided to wrap up its operations in Pakistan, according to industry sources. However, the company has refused to comment on the issue as yet. The American pharmaceutical... - Novo A/S Bags Xellia Pharmaceuticals for $700 Million
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million
OSLO & COPENHAGEN--(BUSINESS WIRE)-- Xellia Pharmaceuticals (Xellia), a pharmaceutical group focusing on... - Royalty Pharma Raises Elan Corporation PLC Bid to $12.50 a Share in Cash
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Royalty Pharma, an investor in royalty streams from pharmaceuticals, raised its offer to buy Elan Corp. (ELN) by 12 percent to $6.4 billion after the Irish drugmaker made acquisitions to boost revenue and resist... - Actavis Nabs Warner Chilcott, PLC for $8.5 Billion
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5 billion which would create the third-biggest specialty pharmaceutical company in the U.S. The announcement on Monday comes after... - There are a Zillion Biotech Conferences. Which Should You Attend?
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Biotech industry conferences are happening, somewhere on this green Earth, every day. If youve been around a while, and youve attended a few, chances are you get invitations, or marketing pitches, that ask... - Puma Biotechnology Gains After Rival Drug Data Show No Threat
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Puma Biotechnology Inc. (PBYI), the maker of an experimental cancer drug, had its biggest two-day gain in seven months after data on a competitor medicine did nothing to diminish analysts expectations. Puma...
- EQUINOX INAUGURE UN NOUVEAU SIÈGE AFRICAIN À LAGOS
- LAGOS, Nigéria--(BUSINESS WIRE)--Equinox International, le fournisseur de premier plan des solutions de technologie d’infrastructures et de services au Moyen Orient et en Afrique du Nord, a annoncé aujourd’hui l’inauguration de son nouveau siège africain à Lagos au Nigéria à l’appui de la stratégie de croissance de l’entreprise. Le bureau d’Equinox en Égypte continuera à servir en tant que siège de la compagnie pour l’ensemble de la région du Moyen Orient et de l’Afrique du Nord. Cet effort d’ex
- La large bande maritime fournie par Thuraya MarineComms répond au dilemme du secteur ; «prix contre qualité»
- Dubaï, Émirats Arabes Unis--(BUSINESS WIRE)--La société Thuraya Telecommunications, l’un des principaux opérateurs en matière de services par satellite, a dévoilé des offres de services d’une nouvelle bande maritime, permettant aux propriétaires et aux managers des navires de profiter des communications maritimes à large bande de haute qualité à des prix convenable. En associant les solutions matérielles fiables et éprouvées de Thuraya à une gamme d'options de tarification, la nouvelle bande mar
- Johnson & Johnson: We're Creaming Medivation, Inc., Boehringer Ingelheim Corporation, Bristol-Myers Squibb Company and Pfizer Inc.
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Im at Johnson & Johnsons Pharmaceutical Business Review today. Most of the day is dedicated to geeky drug R&D stuff, but Joaquin Duato started of the morning with a run-down of how J&Js pharmaceutical division... - Cinnamon May Prevent Alzheimer's Disease, University of California, Santa Barbara Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of -- or warding off -- the... - Novartis AG Admits Employees Participated in Independent Trials
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
For the first time since opening an internal probe into clinical trials run in Japan for its Diovan blood pressure drug, Novartis has acknowledged signs of wrongdoing. In a statement on its web site, the drugmaker... - Schizophrenia Symptoms Eliminated in Animal Model, Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Overexpression of a gene associated with schizophrenia causes classic symptoms of the disorder that are reversed when gene expression returns to normal, scientists report. They genetically engineered mice... - Some Statins Raise Diabetes Risk, British Medical Journal Reveals
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Some drugs taken to protect the heart may increase the risk of developing type-2 diabetes, according to researchers in Canada. Their study of 1.5 million people, in the British Medical Journal, suggested powerful... - Merck & Co., Inc. Drops Development of Parkinson's Drug
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Merck Provides Update on Phase III Clinical Program for Preladenant, the Company's Investigational Parkinson's Disease Medicine
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE... - Got an Itch? National Institutes of Health (NIH) Study May Help Explain Why
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the... - University of Chicago Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science... - University Of Montreal Scientists Discover How Rapamycin Slows Cell Growth
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
University of Montreal researchers have discovered a novel molecular mechanism that can potentially slow the progression of some cancers and other diseases of abnormal growth. In the May 23 edition of the journal... - Drug Giants Such as Bayer AG, Pfizer Inc., and Roche Accused of Shady Soviet-Era Drug Trials
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Germanys Der Spiegel recently published a string of articles indicating that, until the fall of the Berlin Wall, major pharmaceutical companies conducted hundreds of drug trials in East Germany. In all, the... - New Johnson & Johnson Anti-Depressant Related to "Special K" Party Drug
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard medications. The intranasal drug, called... - Social Media Suggests an MS Dogfight Between Biogen, Inc. and Novartis AG
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Over the past month, surveying the track record for the newly launched Tecfidera multiple sclerosis pill has become a closely watched exercise on Wall Street. Each week, analysts pore over prescription data... - BioInvent Recruits as New CEO
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BioInvent recruits Michael Oredsson as new CEO
Lund, Sweden - May 24, 2013 - BioInvent International AB (STO: BINV) announces today that the Company's Board of Directors... - How Much?! AbbVie Raises Niaspan Price Despite Study Failures
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue generated by the pill using a simple business proposition the drugmaker... - Alex Denner Joins VIVUS, Inc. Activist Slate in Post-Icahn Move
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Alex Denner, the former head of health-care investments for billionaire Carl Icahn, joined the activist slate challenging drugmaker Vivus Inc. (VVUS) in the first move of his new fund, Sarissa Capital Management... - Pfizer Inc. to Stay in Madison, 475 Jobs Saved
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Two months after Pfizer announced the sale of its property at 5 Giralda Farms, the company says it's only moving across the corporate campus. Pfizer Consumer Health has entered into a lease agreement for its... - Forest Laboratories, Inc. CEO Finally Listens to and Will Retire
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Carl Icahn has been waiting a long time for this. After years of controversy over his stewardship, Howard Solomon will retire as ceo of Forest Laboratories by the end of the year, and he will relinquish his... - Johnson & Johnson Asks Employees to Assess Its Battered Corporate Credo
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
In the wake of scandals and investigations over manufacturing gaffes, countless product recalls and questionable marketing practices, Johnson & Johnson is embarking on a round of corporate soul searching. The... - MS Patients Choose Death Risk With Biogen Idec, Inc. (Massachusetts)'s Potent Drug Treatment
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Kari Antin, a 40-year-old financial analyst in Minneapolis, knows shes taking a life-or-death risk with every monthly infusion of Biogen (BIIB) Idec Inc.s Tysabri. She is among the 55 percent of multiple... - GlaxoSmithKline to Shut Packaging Plant in Boronia, Laying Off 120 Workers
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SYDNEYGlaxoSmithKline GSK.LN 1.78% PLC said it would close an Australian tablet-packaging facility and lay off 120 workers, joining a string of manufacturers that have shut factories, slashed jobs and relocated... - Got a Wound, Rub Some Dirt in It, Arizona State University Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The colloquial medical advice rub some dirt in it appears to have some merit. Researchers at Arizona State Universitys Biodesign Institute have been experimenting with different clays, and it appears in... - Insomnia Could Lead to Depression, University of Pittsburgh School of Medicine Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A dysfunction in neural circuitry responsible for emotional regulation suggests insomniacs could be at a higher risk for depression, a new study finds. "Insomnia has been consistently identified as a risk... - A Boehringer Ingelheim Corporation Shake Up and an FDA Warning Letter Over Production Gaffes
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
After a string of grave and embarrassing manufacturing problems, Boehringer Ingelheim is overhauling some of its management. Late last week, Boehringer Ingelheim quietly posted on its web site that Wolfram Carius... - BTG plc Buys Ekos for Up to $420 Mllion
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BTG PLC ACQUISITION OF EKOS
23 May 2013 -- A fast-growing and profitable interventional vascular business BTG plc (BTG or the Company), the specialist healthcare company... - Stem-Cell Treatment Restores Sight to Blind Man, Advanced Cell Technology Reveals
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
An experimental stem-cell treatment has restored the sight of a man blinded by the degeneration of his retinal cells. The man, who is taking part in a trial examining the safety of using human embryonic stem... - Universal Flu Jab "Edges Closer," Nature Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A way of creating more effective vaccines which could protect against a broad range of flu viruses has been reported by US researchers. A different seasonal flu jab is produced every year as the virus is a... - Cardeas Pharma Snags $34 Million for Antibiotic Against Hospital Infections
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Seattle-based Cardeas Pharma just raised a lot more cash to fight a big problem that hospitals wrestle with every day, and which theyd rather not say much about publicly. Cardeas, the startup led by prolific... - GlaxoSmithKline Flu Shot May Raise Adult Narcolepsy Risk
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday... - Calcium Can Help Women Live Longer, McGill University Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Taking a calcium supplement of up to 1,000 mg per day can help women live longer, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism... - Your Feet are Home to Nearly 200 Types of Fungi, National Human Genome Research Institute Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Researchers have discovered that there are close to 200 different types of fungi species living on our feet - more than any other part of the body. Although fungi also inhabit other areas of the body - such... - Sandoz, Inc. Recalls Two Lots of Injectable Methotrexate
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Sandoz is conducting a voluntary nationwide recall at the US hospital/user level of 2 lots of its injectable methotrexate sodium, USP, 25 mg/mL, 40 mL vials, as a result of the discovery of particulate matter... - Pfizer Inc. Takes Its Shot at a Vaccine for Evasive MRSA Superbug
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia... - Regeneron Pharmaceuticals, Inc., Sanofi (France) Asthma Drug Seen as Potential Game Changer
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
PARIS and - New Tumor-Killer Shows Great Promise in Suppressing Cancers, Nanyang Technological University and Lund University Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells. This molecule is based on a... - GlaxoSmithKline Gets $200 Million US Contract for Antibiotics
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The collaboration, the first of its... - Teva Pharmaceutical Industries Limited Bets on Reformulating Old Drugs as Investors Say "Show Me"
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts highest-rated stock among the worlds 20 biggest drugmakers, is struggling to convince investors that a key part of its strategy... - University of Louisville Scientists Uncover How Grapefruits Provide a Secret Weapon in Medical Drug Delivery
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Lipids (right panel first three tubes) derived from grapefruit. GNVs can efficiently deliver a variety of therapeutic agents, including DNA, RNA (DIR-GNVs), proteins and anti-cancer drugs (GNVs-Drugs) as demonstrated... - Keeping Stem Cells Strong: RNA Molecule Protects Stem Cells During Inflammation, California Institute of Technology Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness. But repeated infections and inflammation... - Glaucoma Drug Can Cause Droopy Eyelids, Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Prostaglandin analogues (PGAs), drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks. PGAs have long been associated with... - Drink Milk to Increase Child's IQ, University of Surrey Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Mild iodine deficiency during pregnancy could be dimming the intellect of some babies born in the UK, say researchers. Their study of 1,000 families, published in the Lancet, showed lower IQs and reading scores... - Pfizer Inc. to Spin Off Remaining Zoetis Stake in Exchange Offer
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Pfizer Announces Plan for Split-Off of Zoetis
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (PFE) today announced its intention to split off its remaining interest in Zoetis... - Pfizer Inc. Halts Study of Non-Hodgkin's Lymphoma Drug
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility
NEW YORK--(BUSINESS WIRE)-... - Swiss Billionaires Buy Merck Serono HQ for Biotech Campus
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker... - Phagenesis Ltd Expands Series B Financing to $17 Million
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Phagenesis Expands Series B Financing to $17 million
MANCHESTER, England--(BUSINESS WIRE)-- Phagenesis, the worlds leading company in the treatment of dysphagia, has... - Eating Candy Will Not Make You Fat, National Cancer Institute Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
At a time when the spotlight is focused on obesity more than ever, new research suggests that frequency of candy consumption is not associated with weight or certain adverse health risks. According to a recent... - Merck & Co., Inc. Signs $5 Billion Share Buyback Agreement With Goldman, Sachs & Co.
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Merck Announces $5 Billion Accelerated Share Repurchase
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (MRK), known as MSD outside the United States and Canada, today... - Corgenix Medical Corporation Announces Diagnostic Development Agreement With Eli Lilly and Company
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Corgenix Announces Diagnostic Development Agreement with Lilly
DENVER--(BUSINESS WIRE)-- Corgenix Medical Corporation (CONX), a worldwide developer and marketer of diagnostic... - API's From Co's Including Contaminated at Chinese CMO Leads to Canadian Recalls
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Three Canadian drug companies have issued a voluntary recall following potential contamination during manufacturing of an API by their Chinese CMO.
Help employers find you! Check out all the - Wealthy Economic Liberals Actually are Wimps, University of California, Santa Cruz (UCSC) and Aarhus University Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A new study in the journal Psychological Science took a look at the relationship between physical strength and political beliefs. More specifically, the study sought to answer a question: is there any correlation... - GlaxoSmithKline Says Lowering Prices in China Caused Higher Sales
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhDMay 21, 2013 -- Want to increase revenues in China? You might try lowering prices. It seems to have worked for GlaxoSmithKline. In 2009, the company reduced the cost of its...
- Grifols Signs Deal to License Aradigm Corporation's Pulmaquin for Up to $90.7 Million
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin
BARCELONA, Spain & HAYWARD, Calif.--(BUSINESS... - How Bilinguals Switch Between Languages, University of Arizona Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Individuals who learn two languages at an early age seem to switch back and forth between separate "sound systems" for each language, according to new research conducted at the University of Arizona. The research... - Resistance to Last-Line Antibiotic Colistin Makes Bacteria Resistant to Immune System, Emory University Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio, the online open-access journal of the American Society... - IMPAX Laboratories, Inc. Board Steps in to Oversee Hayward Manufacturing Issues
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HAYWARD, Calif. -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that its Board of Directors has established a Compliance Committee composed of three independent directors to provide oversight for... - "Love Hormone" Promises Safer Births After Pfizer Inc. Flop
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A hormone treatment based on technology used in Pfizer (PFE) Inc.s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality. Six years after Pfizer pulled Exubera from the... - University of Wisconsin and New York University Studies Find Link Between Sleep Apnea And Asthma, Alzheimer???s
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Two new studies to be presented at the American Thoracic Society 2013 International Conference in Philadelphia this week found strong associations between sleep apnea and other disorders. In one study, published... - Genetic Predictors of Postpartum Depression Uncovered by Johns Hopkins University Researchers
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The epigenetic modifications, which alter the way genes function without changing the underlying DNA sequence, can apparently be detected in the blood of pregnant women during any trimester, potentially providing... - Testosterone Level Linked to Color of Clothing Men Wear, Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Why do so many sports players and athletes choose to wear the color red when they compete? A new study to be published in Psychological Science, a journal of the Association for Psychological Science, suggests... - INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Insys Therapeutics Inc. has completed its $36.8 million initial public offering to help bolster sales of its medical marijuana drug one of a handful of Arizona IPOs within the past seven months. The resurgence... - Actavis Nabs Warner Chilcott, PLC for $8.5 Billion
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5 billion which would create the third-biggest specialty pharmaceutical company in the U.S. The announcement on Monday comes after... - Effector Therapeutics Raises $45 Million Series A to Fight Cancer Tumors
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
SAN DIEGO, May 20, 2013 /PRNewswire/ -- eFFECTOR Therapeutics, a newly... - Karyopharm Therapeutics Raises $48.2 Million in Series B Financing
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Karyopharm Therapeutics Raises $48.2 Million in Series B Financing
NATICK, Mass., May 20, 2013 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc., a leader in the new... - Puma Biotechnology Gains After Rival Drug Data Show No Threat
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Puma Biotechnology Inc. (PBYI), the maker of an experimental cancer drug, had its biggest two-day gain in seven months after data on a competitor medicine did nothing to diminish analysts expectations. Puma... - Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Roche's obinutuzumab (GA101) significantly reduced the risk of disease progression or death in people with one of the most common forms of blood cancer
Basel, 16 May 2013 -- Roche (SIX: RO... - University of Illinois Study Links Women???s Reproductive Function to their Immune Status
- Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
New research indicates that womens reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females. University of Illinois at Urbana... - US Could Grow Enough Algae to Make 1/12 Nation's Fuel
- The Gulf Coast and Southeast are great for growing algae.
- Glow-in-the-Dark Cockroach, Tiny Frog Among New Species
- Arizona State University scientists have released the top 10 newly discovered species of 2012.
- Is Brad Pitt's Face Blindness For Real?
- Brad Pitt says he can't put a name with a face. Is 'face blindness' a real condition?
- North Cascades | Wallpaper
- Jagged peaks, deep valleys, cascading waterfalls and more than 300 glaciers adorn the North Cascades National Park Service Complex in Washington as seen in this stunning wallpaper.
- Collapsed Washington Bridge Was Old, Obsolete
- A collapsed I-5 bridge was listed as functionally obsolete
- Spin Zone: Physicists Get 1st Look at Strange Quantum Magnetism
- The finding may open the way to understanding superconductivity and other physical phenomena.
- The Best Beaches of 2013 Announced
- A well-known beach in New York snags the top spot ...
- Image Gallery: The Top 10 Beaches of 2013
- Hawaii and Florida of course snagged spots, but No. 1 went to East Hampton in New York.
- Can a Floating Robot Save a Polluted Canal?
- Robots rush in where dolphins fear to tread.
- Human Heart: Anatomy, Function & Facts
- The human heart is an organ that pumps blood throughout the body via the circulatory system.
- What is a Hologram?
- Holography is a photographic technique that records the light scattered from an object, and then presents it in a way that appears three-dimensional.
- Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
- Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
- Life Technologies Announces First Quarter 2013 Results
- Life Technologies Announces First Quarter 2013 Results
- Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
- Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
- Life Technologies Partners with Ridom and Releases SeqSphere+ Software to Speed and Simplify Bacterial Typing
- Life Technologies Partners with Ridom and Releases SeqSphere+ Software to Speed and Simplify Bacterial Typing
- Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor
- Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor
- Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
- Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
- Life Technologies Launches Oncomine® Bioinformatics Solutions for Cancer Researchers
- Life Technologies Launches Oncomine® Bioinformatics Solutions for Cancer Researchers
- Life Technologies Launches Two Ion AmpliSeq™ Community Panel Designs: Ion AmpliSeq™ BRCA1 and BRCA2 Panel and the Ion AmpliSeq™ Colon & Lung Cancer Panel
- Life Technologies Launches Two Ion AmpliSeq™ Community Panel Designs: Ion AmpliSeq™ BRCA1 and BRCA2 Panel and the Ion AmpliSeq™ Colon & Lung Cancer Panel
- BIO Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy
- WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers and posters for the 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 8-11, 2013 in San Diego. Participants may submit proposals for panels in any of five program tracks. Individuals may also submit a single proposal for a 15-
- BIO Joins Coalition of Small Business Innovators
- WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announced today it has joined the Coalition of Small Business Innovators (CSBI). CSBI is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in small, highly innovative companies focused on the development of new technologies. BIO represents over 1,100 biotech innovators in all 50 states. Nationwide, these biotech firms employ 1.61 million Americans and support an add
- BIO Thanks Representatives for Energy Title Amendment to Farm Bill
- WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization thanks Rep. Tim Walz of Minnesota for offering an amendment to the House Farm Bill that would provide mandatory funding to Energy Title programs.
- BIO Praises House of Representatives for Passing H.R. 701
- WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today lauds the House of Representatives for passing H.R. 701, a bill to speed the implementation of a key capital formation provision in the Jumpstart Our Business Startups (JOBS) Act. H.R. 701 was introduced by Rep. Patrick McHenry (R-NC) and passed the House by a vote of 416-6. H.R. 701 will give the U.S. Securities and Exchange Commission (SEC) a deadline to complete rulemaking on the reforms to Regulation A, authoriz
- BIO applauds Rep. David Schweikert for Introducing Spread Pricing Liquidity Act
- WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today thanks Representative David Schweikert (R-AZ) for introducing H.R. 1952, the Spread Pricing Liquidity Act. H.R. 1952 is designed to increase liquidity and spur capital formation for small businesses, including emerging biotech companies that are traded on the public market. Under current U.S. Securities and Exchange Commission (SEC) rules, all securities on the public market are priced in $0.01 increments. This mini
- BIO Thanks Senate Agriculture Committee for Passing Farm Bill
- WASHINGTON--(BUSINESS WIRE)--The Farm Bill energy programs will continue to create jobs. Michigan biotech industry joins the national organization in support of the Senate Farm Bill.
- BIO Applauds Senate Agriculture Committee Draft Farm Bill
- WASHINGTON--(BUSINESS WIRE)--The draft Farm Bill to be debated by the Senate Ag Committee on Tuesday, May 14 provides long-overdue eligibility for renewable chemicals to participate in USDA energy programs.
- BIO to Use ViS Analytics to Streamline Pediatric Clinical Research
- WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) and the ViS Research Institute (ViS) announce a new initiative aimed at improving the efficiency of clinical development for pediatric therapeutics. BIO and its member companies will work with ViS to use its online analytics platform to evaluate global pediatric clinical research infrastructure, identify pediatric patient populations, and empower clinical research collaboration. The U.S. FDA and European Medicines Agency
- BIO Shares U.S. Trade Representative's International Patent Concerns
- WASHINGTON--(BUSINESS WIRE)--BIO expressed concern over the failings of India, China, Brazil and Canada to provide adequate IP protection for biotech companies creating novel and innovative products.
